Objective: To investigate the relationship of dystonia symptoms to cognitive function by comparing cognitive performance in patients with focal (cervical) and generalized dystonia subtypes and examining the differential contributions of severity of symptoms and mood disorders to cognition.
I solated dystonia, formerly called primary dystonia, is a movement disorder of sustained muscle contractions leading to twisting and repetitive movements and/or abnormal postures in patients with no known structural or chemical abnormality (see Fahn et al, 1987) . The distribution of motor symptoms may be focal, affecting one body region only; segmental or multifocal, affecting at least two regions; or generalized, affecting the trunk and at least two other regions (Albanese et al, 2013) . The disorder may be inherited, acquired, or idiopathic (Albanese et al, 2013) . At least three causative genes have been identified and validated: DYT1, DYT6, and DYT25 (Dauer, 2014) .
In addition to the often disabling motor symptoms, several studies have reported that patients with isolated dystonia have cognitive abnormalities (see review by Stamelou et al, 2012) , although the reported abnormalities have been somewhat inconsistent and some findings have been in conflict. Other studies have reported no cognitive impairment at all (Ostrem et al, 2011; Taylor et al, 1991; van Tricht et al, 2012) . The evidence for cognitive impairment in dystonia thus remains controversial.
The differing results may reflect the methods used to assess patients' cognitive profile. Some studies gave patients only a brief assessment battery before concluding that their cognition was preserved (Taylor et al, 1991) . A more comprehensive study by Scott et al (2003) found intact cognition on a range of standard measures of cognitive and executive function, but also selective impairment on one test of executive function, the Intra/ Extra Dimensional Set-Shifting Task from the Cambridge Neuropsychological Test Automated Battery (CANTAB s cognitive assessment software, Cambridge Cognition, Cambridge, United Kingdom, http://www.cantab.com).
Other researchers have also found scattered impairments, mostly on tests of executive function. For example, Jahanashahi et al (2003) reported impairments in category fluency and dual tasking, Bugalho and colleagues (2008) reported an elevated number of perseverations on the Wisconsin Card Sorting Test (Berg, 1948) , and van Tricht et al (2012) reported impairment in category fluency and the Trail Making Test, Part B (TMT-B) (Reitan and Wolfson, 1985) . A few studies have also reported impairment in visual and verbal memory (Balas et al, 2006; Romano et al, 2012) . Stamelou and colleagues (2012) argued that any cognitive deficits observed may simply reflect more basic factors, such as the distracting effects of motor symptoms. In keeping with this argument, Allam and colleagues (2007) found that cognition in nine patients with cranial dystonia improved after they were treated with botulinum toxin. By contrast, Gonzalez Alema´n et al (2009) found that cognitive function in 20 patients with blepharospasm was independent of symptom severity or duration. Thus, it remains unclear if motor symptoms can fully account for patients' cognitive deficits.
No study to date has directly compared cognition across different dystonia subtypes. If the cognitive deficits simply reflected the intrusiveness of motor symptoms, it might be hypothesized that more generalized and/or severe symptoms would be associated with greater cognitive impairment than that observed in patients with more focal or milder presentations.
Further, although it is well recognized that the incidence of mood disorders is elevated in patients with dystonia (Bugalho et al, 2008; Kleiner-Fisman et al, 2007; Ostrem et al, 2011; van Tricht et al, 2012) , few studies have examined the relationship between cognition and mood. Van Tricht et al (2012) found that patients with isolated dystonia who also had a history of anxiety performed worse on a measure of working memory, and Jahanashahi et al (2003) found that patients with higher depression scores did worse on a measure of executive function. These findings raise the possibility that any cognitive impairment might reflect the impact of a mood disorder.
Our present study had four specific aims:
To compare cognition between patients with isolated dystonia and age-matched healthy controls To look for any differences in cognition between focal and generalized dystonia; we chose to study patients with the most common type of focal dystonia, cervical dystonia To consider how other relevant clinical factors, such as severity of symptoms and medications, might affect cognition To examine the relative contribution of mood to cognition Based on previous findings, we expected to see evidence of cognitive impairment and mood disorder in isolated dystonia, but we could not predict how these features would relate to the clinical factors.
METHODS

Participants
Our study participants were patients with an established diagnosis of either cervical or generalized dystonia who attended the Neuropsychology Department of the National Hospital for Neurology and Neurosurgery, Queen Square, London. These patients had been referred to the Neuropsychology Department between 2008 and 2013 as part of a multidisciplinary assessment to determine whether they qualified for surgical treatment of their dystonic symptoms.
We screened the patients' records for eligibility for our study. Our exclusion criteria were a history of a traumatic, neurologic, psychiatric, or systemic disorder; a history of alcohol and/or drug abuse; and not being a native English speaker. From the original group of 43 candidates, we excluded five: two for dystonia secondary to postanoxic injury, one for tardive dystonia, one for a history of alcoholism, and one for not being a native English speaker.
Of the remaining 38 patients, 25 had confirmed diagnoses of cervical dystonia and 13 had generalized dystonia.
Nine of the patients with generalized dystonia likely had inherited forms, as confirmed by genetic testing previously done elsewhere. Of these nine patients, seven had the DYT1 gene, one had DYT6, and the remaining patient had an autosomal-dominant pattern of inheritance but no specific gene identified. The four other patients with generalized dystonia tested negative for DYT1 and had been given a diagnosis of idiopathic isolated dystonia. We could not get information on whether the patients with cervical dystonia had undergone genetic testing.
The severity of the patients' dystonia was independently rated by the Functional Neurosurgery Department using the Burke-Fahn-Marsden Dystonia Rating Scale (Burke et al, 1985) . If patients were taking medications for their dystonia symptoms, they were rated while on their usual regimen. Of the total of 38 patients, 33 were taking one or more such medications when they were tested: 21/25 with cervical dystonia and 12/13 with generalized dystonia. Their medications were antimuscarinics (trihexyphenidyl in 11 patients, botulinum toxin in 18, and tetrabenazine in one), hypnotics (clonazepam in seven, diazepam in six, and chlorodiazepoxide in one), relaxants (baclofen in two), and antidepressants in seven.
We compared the patients to 50 age-matched healthy controls who had taken part in an earlier departmental study. We screened their records to ensure that they fulfilled the same criteria for our study as the patients. The controls had no known history of a traumatic, neurologic, psychiatric, or systemic disorder, or alcohol or drug abuse, and all were native English speakers. Table 1 
Cognitive Assessment
As part of the patients' multidisciplinary assessment, the Neuropsychology Department staff had given them the following standardized neuropsychological measures of general intellectual function, memory abilities, attention and executive function, speed of information processing, and mood.
Global Cognitive Function
The Neuropsychology staff tested the patients' current level of intellectual function using the Wechsler Adult Intelligence Scale-Third Edition (WAIS-III) (Wechsler, 1997) , prorated to generate scores for verbal and nonverbal intellectual abilities. The staff used the National Adult Reading Test (NART) (Nelson, 1982) to estimate premorbid level of intellectual function by generating each patient's Predicted Full-Scale IQ (intelligence quotient). They gave the Mini-Mental State Examination as a screening test of global cognitive function (Folstein et al, 1975) . To rule out a global cognitive disorder, they tested the patients' naming abilities with the Graded Naming Test (McKenna and Warrington, 1983) and their visuoperceptual skills with the Silhouettes and/or Incomplete Letters tests from the Visual Object and Space Perception Battery) (Warrington and James, 1991) .
Memory
The staff assessed the patients' visual and verbal recognition memory using the Recognition Memory Test (Warrington, 1984) .
Attention and Executive Function
The staff assessed the patients' attention and executive function using the Elevator Counting subtests from the Test of Everyday Attention (Robertson et al, 1994) , the TMT-B (Reitan and Wolfson, 1985) , Modified Card Sorting Test (Nelson, 1976) , Brixton Spatial Anticipation Test (Burgess and Shallice, 1997) , Stroop test (Trenerry et al, 1989) , Hayling Sentence Completion Test (Burgess and Shallice, 1997) , and phonemic verbal fluency with the letters F-A-S) (Spreen and Strauss, 1998) .
Speed of Information Processing
The staff assessed the patients' speed of information processing using Part A of the Trail Making Test (TMT-A) (Reitan and Wolfson, 1985) and the Symbol Search and Digit Symbol Coding subtests from the WAIS-III (Wechsler, 1997) .
Mood
The staff screened for mood disorders using the Hospital Anxiety and Depression Scale (Zigmond and Snaith, 1983 ) and the Apathy Evaluation Scale (Marin et al, 1991) .
The healthy controls had completed an abbreviated version of this full assessment, comprising the WAIS-III, 
Statistical Analysis
We calculated means and standard deviations for each of the raw scores on the measures. Before analysis, we log transformed all data to achieve near-normal distributions. We calculated frequency of impairment (scores below the 5th percentile) on each test relative to published normative data. We set the significance level at 0.05, adjusted for multiple comparisons as required.
RESULTS
Patients
All 38 patients scored at or above 27/30 on the Mini-Mental State Examination and above the 5th percentile on the Graded Naming Test and the Silhouettes and/or Incomplete Letters tests of visual function.
Cervical Versus Generalized Dystonia
As shown in Table 1 , the patients with generalized dystonia were significantly younger than those with cervical dystonia: t 36 = À 5.04, P < 0.001, r = 0.45, but the two groups had no significant differences on the NART Predicted Full-Scale IQ. The generalized dystonia group also had a significantly younger age at dystonia onset than the cervical group: t 34 = À 5.25, P < 0.001, r = 0.67, as well as greater severity of their movement disorder: t 14 = 4.35, P < 0.001, r = 0.76, and disability: t 14 = 4.30, P < 0.001, r = 0.75. Table 2 shows our comparison of neuropsychological test scores between the two dystonia groups and the controls. To compare mean test scores, we used analyses of covariance, with age as a covariate, and we adjusted for multiple comparisons using Bonferroni correction.
There were no significant differences in test results between the two dystonia groups. w 2 tests revealed no significant associations between subtype of dystonia and frequency of neuropsychological impairment.
Combined Dystonia Groups Versus Controls
Next we combined the two dystonia groups into one and compared it with the controls. We found no significant differences in mean age, NART, WAIS-III, or memory. However, the combined dystonia group did significantly worse on the TMT-B (t 54 = 4.05, P < 0.001, r = 0.43) and TMT-A (t 53 = 2.25, P < 0.05, r = 0.32). TMT-A scores were related to TMT-B scores: F 1,52 = 21.75, P < 0.001, r = 0.99. However, a significant difference in TMT-B remained between the combined dystonia group and the controls after we controlled for TMT-A (F 1,52 = 9.62, P < 0.05, r = 0.81).
Although we found no significant group difference in mean age between the two dystonia groups, we conducted an analysis of covariance to consider if the differing age ranges might have contributed to the significant group difference on the TMT-B. The analysis confirmed that age was not a significant factor. Further, although a w 2 test revealed no significant association between participant group and frequency of impairment, it is notable that five of the patients with dystonia scored in the impaired range on the TMT-B (<10th percentile), while none of the controls did, and no participant in either group scored in the impaired range on the TMT-A.
The patients also did significantly worse than the controls on the Stroop test: t 44.71 = À 2.11, P < 0.05, r = 0.27. However, despite log transformation, the patients' scores remained significantly negatively skewed ( z skewness = À 6.98), with insufficient homogeneity of variance: F 1,70 = 10.73, P < 0.05. Again, a w 2 test revealed no significant association between participant group and frequency of impairment, but four of the patients scored in the impaired range (<10th percentile), while none of the controls did. Two of these four patients scored significantly below the group mean (À 4.67 and À 2.68). The first of these patients had cervical dystonia and was taking botulinum toxin. The second had DYT1 generalized dystonia and was on antidepressant medication. When we removed these two outliers from the analysis, the group difference was no longer significant.
A w 2 test did reveal a significant association between group and frequency of impairment on the Hayling Sentence Completion Test: Six of the patients scored in the impaired range (scaled score <4), while all of the controls scored in the normal range: w 1 2 = 5.85, P < 0.05. However, an analysis of variance revealed no significant difference in mean scores.
In sum, 12 of the 38 patients with dystonia performed in the impaired range on at least one of the TMT-B, Stroop, and Hayling tests. One patient scored in the impaired range on all three, one patient was impaired on the Stroop and Hayling only, and the 10 remaining patients were impaired on only one test: four on the TMT-B, four on the Hayling, and two on the Stroop. Both of the patients with more than one impairment had a diagnosis of cervical dystonia, but the 10 other patients were equally split, five with cervical and five with generalized dystonia. Post hoc analyses revealed no significant group differences in age, mood, or severity of dystonia between those who were impaired on at least one test and those who were cognitively intact.
Contribution of Dystonia Variables
For the combined dystonia groups, we found no significant correlations between neuropsychological test scores and dystonia variables, ie, age at onset, duration of the condition, severity of the movement disorder, and severity of disability. When we used a median split to divide the patients into two groups according to the severity of their movement disorder, we found no significant differences in their scores.
After Bonferroni correction, we saw no significant differences in scores between the 33 patients who were taking medications at the time of testing and the five who were not. The 15 patients who were taking trihexyphenidyl or hypnotics-medications thought to cause particularly serious cognitive side-effects-did not differ significantly from the 23 others.
Mood Assessment
The patients showed high rates of mood disorders on the Hospital Anxiety and Depression Scale and the Apathy Evaluation Scale. Twenty of the 38 patients tested above the cutoff for anxiety, with a mean score of 7.53 (standard deviation = 3.97). Eleven patients tested above the cutoff for depression, with a mean score of 5.79 (standard deviation = 3.75). Fourteen tested above the cutoff for apathy, with a mean score of 12.00 (standard deviation = 8.02), and seven of these people scored above the cutoffs for both depression and apathy. Depression and anxiety scores were highly intercorrelated (r = 0.63, P < 0.001), with a significant association between depression and apathy (r = 0.59, P < 0.001).
The two patient groups had no significant differences in mood. Mood was not significantly related to age at dystonia onset, duration of the condition, severity of movement disorder, or disability. We found no significant group differences between the seven patients with a severe mood disorder (score >11 for either anxiety or depression) and the 19 patients with a mild mood disorder. We found no association between mood and any of the neuropsychological scores, or between a mild or severe mood disorder and frequency of cognitive impairment or severity of symptoms.
DISCUSSION
Several studies have reported cognitive impairment in patients with isolated dystonia and have argued that this may simply reflect the distracting effects of the dystonia symptoms and/or a mood disorder. We compared cognition in patients with the focal (cervical) and generalized subtypes of isolated dystonia on a comprehensive range of neuropsychological assessments. We found no significant differences between the patients with cervical and generalized dystonia in mean performance or frequency of impairment, despite those with generalized dystonia having more severe and disabling motor symptoms. This finding suggests that severity of motor symptoms has little or no impact on patients' cognition.
Indeed, our correlational analyses revealed no significant associations between symptom severity and performance on any measure of cognitive function. Neither was cognition associated with age at onset or duration of dystonia.
There was no significant difference in cognition between those patients using and those not using any medication, or between those using and those not using medications with greater cognitive side-effect profiles.
Although our small sample size precluded further analysis to seek subtle medication effects, our current findings suggest that cognition is independent of medications.
When we compared the patients with healthy controls, we found that on the whole the patients performed less well on the TMT. Two patients also showed impairment on the Stroop test and six were impaired on the Hayling Sentence Completion Test. In total, nearly a third of all the patients demonstrated impairment on at least one test of executive function, while none of the controls did. This relative deficit in executive function is in keeping with several previous reports (Bugalho et al, 2008; Jahanashahi et al, 2003; Kleiner-Fisman et al, 2007; Romano et al, 2012; Scott et al, 2003; van Tricht et al, 2012) . Importantly, this deficit does not appear to be explained by a more basic fluctuation in attentional abilities caused by distracting effects of dystonic symptoms, as we did not find that symptom severity related to performance on any measure of executive function.
We should note, however, that poor performance on the TMT has been found to be a nonspecific marker of brain dysfunction (Chan et al, 2015; Demakis, 2004) . We are also not sure whether we can draw any strong conclusions from impaired Stroop scores in only two patients. Thus, although we found evidence of subtle cognitive symptoms, which may have serious implications for affected patients and should be recognized as part of the syndrome, we found no indication of a pervasive or significant cognitive impairment. The subtlety of these cognitive symptoms may explain why several previous studies have reported preservation of cognitive function in dystonia (Ostrem et al, 2011; Taylor et al, 1991; Vidalihet et al, 2005) .
It seems unlikely that the little evidence of cognitive impairment that we found in this patient sample is simply attributable to the number of participants. Our patient sample of 38 is larger than most previously published studies (Balas et al, 2006; Jahanashahi et al, 2003; Kleiner-Fisman et al, 2007; Ostrem et al, 2011; Scott et al, 2003; Taylor et al, 1991; Vidalihet et al, 2005) . Studies with similar sizes to ours and those with larger samples (of up to 51 patients) have also reported scattered impairments on tests of executive function (Bugalho et al, 2008; Romano et al, 2012; van Tricht et al, 2012) . However, because those studies did not include a control sample or use a comprehensive battery of cognitive assessments, we cannot directly compare our findings with theirs.
Our patients had a high rate of anxiety and depression, and around half of our sample met criteria for a mood disorder. These figures are similar to those reported previously (Bugalho et al, 2008; Jahanashahi et al, 2003; Kleiner-Fisman et al, 2007; Kuyper et al, 2011; Ostrem et al, 2011; Scott et al, 2003; van Tricht et al, 2012) . Still, we found no significant relationship between mood and cognition. A few studies reported a correlation between mood symptoms and cognitive function (Jahanashahi et al, 2003; van Tricht et al, 2012) , but another large study did not (Bugalho et al, 2008) , suggesting that the cognitive profile does not simply reflect mood.
Furthermore, our patients' mood symptoms were not associated with features of their dystonia. This finding is in keeping with earlier research showing that mood symptoms often precede the onset of motor symptoms. This sequence may explain why dystonia was once thought of as a manifestation of a psychiatric disturbance (Kuyper et al, 2011) . This sequence also raises the possibility that the mood disorder seen in patients with dystonia may actually represent yet another clinical manifestation of the disorder itself, rather than simply being a reaction to it (Fabbrini et al, 2010) . Indeed, genetic analyses have shown higher rates of mood disorders in symptomatic and asymptomatic carriers of the DYT1 gene mutation than in controls, with asymptomatic carriers demonstrating a four-fold higher risk of developing depression (Heiman et al, 2004) . Thus, growing evidence suggests that the mood symptoms represent an important facet of the dystonia nonmotor syndrome.
In conclusion, this study has shown that poor performance on cognitive tests by patients with dystonia does not simply reflect the distracting influence of the motor symptoms and/or a mood disorder. Rather, the nonmotor features of dystonia include subtle cognitive symptoms and high rates of mood disorders, both of which occur independent of motor symptom severity and level of disability. Thus, we would argue that isolated dystonia is a tripartite disorder, with motor, affective, and subtle cognitive features.
